Sir Andrew Witty was the BIS Lead Non-Executive until February 2014.
Andrew became CEO of GlaxoSmithKline (GSK) in May 2008. Before this he held a variety of roles within the company both in the UK and overseas before being appointed President of GSK Europe and joining GSK’s Corporate Executive Team in 2003.
Andrew has served in numerous advisory roles to governments around the world including South Africa, Singapore, China and the UK. Andrew is also President of the European Federation of Pharmaceutical Industries and Associations and the Chancellor of the University of Nottingham.